Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
54
CVSB Quote, Financials, Valuation and Earnings
Last price:
$50.74
Seasonality move
:
0.27%
Day range:
$50.72 - $50.78
52-week range:
$50.26 - $51.10
Dividend yield:
4.71%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
18.4K
Avg. volume:
12.3K
1-year change:
0.02%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Calvert Ultra-Short Investment Grade ETF has -- downside to fair value with a price target of -- per share.
CVSB vs. S&P 500
-
Over the past 5 trading days, Calvert Ultra-Short Investment Grade ETF has underperformed the S&P 500 by -1.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Calvert Ultra-Short Investment Grade ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Calvert Ultra-Short Investment Grade ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Calvert Ultra-Short Investment Grade ETF reported revenues of --.
Earnings Growth
-
Calvert Ultra-Short Investment Grade ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Calvert Ultra-Short Investment Grade ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-08 | 2025-01-08 | 2025-01-08 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2022-01-08 | 2023-01-08 | 2024-01-08 | 2025-01-08 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-08 | 2025-01-08 | 2025-01-08 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CVSB
Sector
Market Cap
--
--
Price % of 52-Week High
99.35%
--
Dividend Yield
4.71%
--
Shareholder Yield
--
--
1-Year Price Total Return
0.02%
--
Beta (5-Year)
--
--
Dividend yield:
4.71%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$50.74
200-day SMA
Buy
Level
$50.74
Bollinger Bands (100)
Sell
Level
50.73 - 50.85
Chaikin Money Flow
Buy
Level
1.1M
20-day SMA
Buy
Level
$50.76
Relative Strength Index (RSI14)
Buy
Level
52.11
ADX Line
Sell
Level
14.41
Williams %R
Neutral
Level
-34.6154
50-day SMA
Sell
Level
$50.78
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-4
On Balance Volume
Neutral
Level
4.5M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, CVSB has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CVSB average analyst price target in the past 3 months is --.
-
Where Will Calvert Ultra-Short Investment Grade ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that Calvert Ultra-Short Investment Grade ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Calvert Ultra-Short Investment Grade ETF?
Analysts are divided on their view about Calvert Ultra-Short Investment Grade ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Calvert Ultra-Short Investment Grade ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is Calvert Ultra-Short Investment Grade ETF's Price Target?
The price target for Calvert Ultra-Short Investment Grade ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CVSB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Calvert Ultra-Short Investment Grade ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CVSB?
You can purchase shares of Calvert Ultra-Short Investment Grade ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Calvert Ultra-Short Investment Grade ETF shares.
-
What Is The Calvert Ultra-Short Investment Grade ETF Share Price Today?
Calvert Ultra-Short Investment Grade ETF was last trading at $50.74 per share. This represents the most recent stock quote for Calvert Ultra-Short Investment Grade ETF. Yesterday, Calvert Ultra-Short Investment Grade ETF closed at $50.77 per share.
-
How To Buy Calvert Ultra-Short Investment Grade ETF Stock Online?
In order to purchase Calvert Ultra-Short Investment Grade ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CVSB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CVSB
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
--
--
Price / LTM sales
--
--
Growth Metrics
CVSB
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
CVSB
Sector
Profitability FY 2025
--
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Jan
8
Next Earnings Date
Jan
8
Estimated Next Earnings Date
Apr
9
Balance Sheet
CVSB
Sector
Total cash
--
--
Short term investments
--
--
Total assets
--
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
69
RGC alert for Jan 7
Regencell Bioscience Holdings Ltd. [RGC] is up 58.95% over the past day.
Buy
69
WDC alert for Jan 7
Western Digital Corp. [WDC] is down 8.88% over the past day.
Buy
75
DRUG alert for Jan 7
Bright Minds Biosciences, Inc. [DRUG] is up 2.99% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
